Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – Wall Street Journal
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …Wall Street JournalInvitrx Therapeutics is a biotechnology company specializing in the culture and engineering of adult stem cells, innovative products and therapies that are used in aesthetics, wound closure, and healing, as well as, plastic and reconstructive surgery … …read more &nbs… Continue reading
